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Umbilical vein function and birth mode
Abstract
The current study investigated whether the mode of delivery and 
the mode of sample collection affect the functional properties of 
umbilical veins as scaffolds for vascular tissue engineering pur-
poses.  HUV from planned  c-sections  (PCS)  showed  a  1.7-fold 
higher maximum contraction with potassium chloride compared 
to spontaneous vaginal deliveries (VD, p=0.029). The maximum 
contractions with histamine were 2.0-fold and 2.9-fold higher in 
the  PCS  and  emergency  c-section  (ECS)  groups,  respectively, 
compared to the VD group (p=0.003). The dose-response curves 
of serotonin were shifted to the right approx. 6-fold and 5-fold in 
the VD group compared to PCS and ECS, respectively (p=0.009). 
There were no differences between the birth groups in terms of 
tetrazolium dye reduction, platelet adhesion, and the structural 
integrity. The release of the antithrombotic compound prostacyc-
lin from vessels of the PCS and ECS groups was 6.6-fold and 3.5-
fold higher, respectively, than in the VD group (p<0.001). There 
was no correlation between the duration of ischemia and any of 
the functional parameters. This study provides evidence that ves-
sels obtained from PCS are to be preferred for tissue engineering 
purposes, as they can be harvested in a sterile fashion and show 
superior  vasoconstrictor  responses  and antithrombotic  proper-
ties. The data also support a once-per-day pickup schedule for 
umbilical cords without a deterioration of the functional proper-
ties.
1. Introduction
Bypassing stenoses in coronary arteries requires small caliber grafts 
with  unique  properties.  In  contrast  to  vascular  reconstructions  in 
large-diameter vessels like aorta, the antithrombotic properties of the 
graft surface as well as its viscoelastic properties are of critical import-
ance. To date, there is no clinically suitable bypass material based on 
synthetic polymers. Although endothelial seeding greatly improves the 
patency  of  e.g.  PTFE  grafts [1],  the  compliance  mismatch  between 
grafts and coronary arteries remains to be solved [2]. It is now widely 
recognized that extracellular matrix (ECM) would make an ideal scaf-
fold for therapeutic applications [3]. Deendothelialized human umbil-
ical vein (HUV) has recently been suggested as a living scaffold for vas-
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cular tissue engineering [4]. Umbilical cords are a cheap and abundant 
source of stem cells and of vascular tissue, with recruitment rates ex-
ceeding 60% of all  births in an ongoing study [5]. Deendothelialized 
HUV contain ECM with suitable viscoelastic properties [6] along with 
fetal  smooth  muscle  cells  which  can synthesize  and remodel  ECM. 
Turning this semifinished biomaterial into a vascular graft will require 
two tissue engineering processes. First, in order to provide a hemocom-
patible and non-immunogenic surface, endothelial function has to be 
restored by seeding recipient-derived endothelial cells (EC). Second, the 
graft has to mature in a pulsatile bioreactor to create a wall structure 
and EC alignment suitable for the pressure and shear forces of the 
coronary circulation [7]. The quality of a vessel replacement engineered 
from umbilical vessels, and the difficulties associated with the engin-
eering process, are likely to depend on the quality of the starting ma-
terial.  Therefore,  the current study investigated the influence of  the 
mode of birth on the functional properties of HUV.
The influence of the birth mode on the physiology of neonates has been 
investigated in several studies. It is generally accepted that delivery by 
a planned (elective) cesarean section (PCS) is less stressful for the fetus 
than a spontaneous vaginal delivery (VD). There is a body of evidence 
that PCS causes less oxidative stress as measured by the levels of lipid 
peroxidation products [8,9] and of the antioxidant glutathione [10] in 
the cord blood. Along the same lines, the levels of the stress indicators 
cortisol [11], progesterone [12], and norepinephrine [13] as well as the 
number of CD34+ mononuclear cells [14] in the cord blood are lower 
after a PCS. This study tried to address the question whether the same 
differences affect the performance of HUV post partum.
With the exception of PCS, the exact time of birth, and thus the time of 
umbilical  cord sample  collection,  is  difficult  to  predict.  Moreover,  a 
large proportion of births occur at times which are inconvenient for a 
routine tissue engineering protocol. The situation is aggravated if, as it 
was the case in the present study, the samples have to be processed 
outside of the hospitals that provide them. This warranted an investig-
ation whether the quality of HUV depends on the duration of ischemia.
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2. Materials and Methods
2.1. Materials and Reagents
Calcein  AM was  supplied  by  Molecular  Probes  (Eugene,  OR,  USA). 
Hank's Balanced Salt Solution (HBSS) was purchased from Invitrogen 
(Carlsbad, CA, USA), and fetal calf serum (FCS) was obtained from PAN 
(Aidenbach, Germany). All other reagents were of analytical grade and 
were  purchased from Sigma (Taufkirchen,  Germany)  or  from Merck 
(Darmstadt, Germany).
2.2. Subjects and harvesting of umbilical cords
A random and unselected group of pregnant women was recruited for 
the study [5] when they first reported to the maternity wards in the two 
participating medical centers, and written informed consent was ob-
tained.  The  experiments  were  approved  by  the  institutional  review 
boards of both universities. A total of 40 VD, 19 PCS, and 18 ECS were 
included into the study. Patients with known contagious diseases like 
HIV or hepatitis were excluded.
The samples were divided into three groups according to the mode of 
delivery. The VD group contained all vaginal deliveries. The PCS group 
received all c-sections that were started before the onset of labor due to 
a medical indication or in response to the expectant mother's request. 
The ECS group received all c-sections that commenced after the onset 
of labor.
Samples of the umbilical cords originating from Klinik St. Hedwig were 
stored in Krebs-Henseleit buffer (KHB; NaCl 118 mM, KCl 4.7 mM, Mg-
SO
4




 1.2 mM, NaHCO
3
 16.7 mM, dextrose 5.5 mM, 
CaCl
2
 1.2 mM)  supplemented  with  HEPES  (25 mM),  penicillin 
(100 U/ml),  and  streptomycin  (100 μg/ml)  at  4°C  immediately  after 
parturition  and  transported  to  the  lab.  Cords  originating  from 
Klinikum Rechts der Isar were stored in HF-1 buffer (HBSS supple-
mented  with  HEPES  1 mM,  penicillin  100 U/ml,  streptomycin 
100 μg/ml, and FCS 1%). The minor difference in the storage solutions 
had logistic reasons only  and did not  affect  the performance of  the 
veins. In pilot transports a digital thermometer recorded the minimum 
and maximum temperatures inside the containers. The temperatures 
did not exceed 16°C during summer.
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Areas of the umbilical cords visibly damaged by clamps were excluded 
from the analysis. The HUV were dissected free from Wharton's Jelly, 
both to simplify handling and to properly model the situation of a tis-
sue-engineered graft. The vessels were either cut into rings of 2 mm 
segment length for organ bath studies, or they were carefully opened 
longitudinally for functional studies of the vessel surface. Due to size 
constraints it was not possible to run each functional assay on every 
sample. Instead, the veins were randomly assigned to one or more as-
says until a sufficient number of data points were available per assay.
2.3. Organ bath studies
The tension of HUV rings was determined isometrically in an IOA-5300 
organ  bath  system (FMI  GmbH,  Seeheim/Ober-Beerbach,  Germany) 
filled with KHB under hypoxic conditions (5% oxygen, 5% carbon diox-
ide, balance nitrogen) as described previously [4]. Four to eight rings of 
each HUV were used per experiment. In studies involving the relaxa-
tion of the vessels, one or two rings were randomly assigned to a time 
control group which did not receive the relaxing agent. The effect of re-
laxing agents was computed relative to these time controls to account 
for the spontaneous loss of tension over time.
2.4. Histology
HUV were fixed in phosphate-buffered paraformaldehyde (4%) and em-
bedded in paraffin.  Thin  sections were stained with Russell-Movat's 
Pentachrome  procedure  according  to  the  manufacturer's  protocol 
(American MasterTech Scientific, Lodi, CA, USA) to assess the appear-
ance of smooth muscle, collagen, and elastic fibers as well as the con-
dition of the endothelium.
2.5. Scanning electron microscopy
HUV were fixed in phosphate-buffered paraformaldehyde (2%) supple-
mented with 2.5% glutardialdehyde and cut longitudinally into half or 
quarter segments. The samples were then dehydrated and sputtered 
with gold. Scanning electron micrographs were created on a Quanta-
400F scanning electron microscope (FEI, Hillsboro, OR, USA) using an 
accelerating voltage of 10 kV.
Scanning electron micrographs were evaluated by an independent re-
viewer in a blinded fashion.  Overview images at 200x magnification 
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were scanned for cracks and missing patches of endothelium. Each im-
age was assigned an estimated percentage, in increments of 10%, of in-
tact endothelial coverage. Preparation artifacts, if any, were assumed 
to affect all groups to the same degree.
2.6. Platelet adhesion assay
The adhesion of human platelets to the luminal vessel surface was de-
termined as described previously [4].  In brief,  longitudinally  opened 
HUVs  were  mounted  in  tissue  holders,  which  allowed  access  to  a 
defined area (0.33cm2)  of the luminal surface, and incubated with a 
suspension of Calcein AM-labelled platelets of a known concentration. 
After an incubation at 37°C for 30 min, the suspension was aspirated, 
and the wells were washed three times with phosphate-buffered saline. 
The adhering platelets were lysed using 1% Triton X-100, and the re-
leased  amount  of  Calcein  AM in  the  supernatants  was  determined 
fluorometrically.  A  calibration curve  was constructed from a known 
amount of the same labelled platelets on polystyrene culture plates. 
The data are reported relative to the number of platelets per area ad-
hering to polystyrene under the same conditions.
2.7. Tetrazolium dye reduction
The conversion of the chromogenic substrate 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS,  Promega,  Madison,  WI,  USA)  was determined on the  luminal 
surface  of  longitudinally  opened HUVs mounted in the  same vessel 
holders as mentioned above and evaluated as described previously [4].
2.8. Determination of prostacyclin release
The luminal surfaces of HUVs mounted in vessel holders were incub-
ated in an incubation buffer containing PBS supplemented with 5 mM 
dextrose,  0.5 mM MgCl
2
,  and 1.2 mM CaCl
2
 for  10 s,  1 min,  3 min, 
10 min, and 15 min at 37°C to assess the basal release of prostacyclin. 
The supernatants were stored at -80°C and analyzed using an enzyme-
linked immunosorbent assay kit according to the manufacturers pro-
tocol (Cayman Chemicals, Ann Arbor, MI, USA). The rates of prostacyc-
lin release were determined by computing a linear regression fit to the 
average concentrations at each timepoint.
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2.9. Data analysis and statistics
Quantitative data are reported as mean±standard deviation. Half max-
imal  effective  concentrations  (EC
50
)  and  maximum  response  values 
were computed from the dose-response curves of each sample by fitting 
a Hill function. The means of the EC
50
 values were then computed for 
each birth mode.  Differences in demographic data  and in serotonin 
dose-response curves between birth modes were analyzed using AN-
OVA followed by the Kruskal-Wallis or the Holm-Sidak test as appro-
priate. Histamine dose-response curves were expressed as the ratio of 
the sample tensions and the donor-matched time control tensions to 
account for a time-dependent loss of tension. Within each birth mode, 
two-way repeated measurements ANOVA was used to detect a signific-
ant  difference  between  histamine  and  control  curves.  In  addition, 
sample curves were compared between birth modes using two-way AN-
OVA. Prostacyclin release rates were compared using two-way ANOVA, 
again followed by the Holm-Sidak test. Endothelial coverage was com-
pared with the Mann-Whitney rank sum test. A statistically significant 
difference was assumed for p<0.05.
3. Results
3.1. Maternal and sample characteristics
Table 1 shows the maternal characteristics as well as the physiologic 
parameters of the neonates. All but four births occurred at gestational 
ages of 37+0 weeks or later. The four pre-term births were distributed 
evenly between VD and c-sections, and none of these pregnancies was 
shorter than 35+6 weeks. The duration of pregnancies terminated with 
a PCS was significantly shorter compared to the VD and ECS groups 
(ANOVA, p<0.001), and the birth weights of the newborns were lower 
compared to the VD group (ANOVA, p=0.002). The mean ages of moth-
ers were not different between the modes of delivery (ANOVA, p=0.054), 
although the ages of mothers having an emergency c-section tended to 
be higher. The pH of the arterial umbilical cord blood was not signific-
antly different between the groups (ANOVA, p=0.056), but vaginal de-
liveries tended to result in a lower arterial pH. The Apgar values at 5 
and  10 min  were  significantly  higher  in  vaginal  deliveries  (ANOVA, 
p<0.001).  The  duration of  ischemia,  measured as the  time between 
birth and the start of the vessel preparation in the lab, was signific-
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antly longer in PCS compared to VD (ANOVA, p=0.043).
3.2. Effects of vasoactive compounds
HUVs  were  contracted  by  depolarizing  the  smooth  muscle  with 
150 mM KCl (Fig. 1). The maximum tensions of HUVs obtained from 
VD were significantly lower compared to those obtained from PCS (AN-
OVA, p=0.029), reaching only 56.6 % of the tension of the latter. To as-
sess the  receptor-mediated contraction,  dose-response  curves of  the 
vasoconstrictor serotonin (5-hydroxytryptamine) were constructed (Fig. 
2). The curves obtained from the c-section groups were found to differ 
significantly from the curves obtained from the VD group (two-way AN-
OVA, p<0.001). The EC
50
 values of HUVs obtained from PCS (5.71E-9, 
logEC
50
=-8.24±0.62)  and  of  HUVs  obtained  from  ECS  (6.88E-9,  lo-
gEC
50
=-8.16±0.26) were significantly lower than of those obtained from 
VD  (3.36E-8,  logEC
50
=-7.47±0.46,  ANOVA,  p=0.009).  The  maximum 
tensions  of  both  PCS  and  ECS  vessel  rings  were  not  significantly 
higher compared to vessels from VD (ANOVA, p=0.057). Figure 3 shows 
that there was no correlation between ischemia time and maximum 
contraction  by  KCl  (r2=0.027)  or  by  serotonin  (r2=0.019)  as  well  as 
between ischemia time and EC
50
 of serotonin (r2=7.71E-3).
We assessed the endothelium-dependent relaxation of vessel rings by 
administering a concentration series of histamine after preconstriction 
with serotonin (Fig. 4). We observed no significant relaxation in any of 
the groups. However, all groups showed a significant vasoconstriction 
at  histamine concentrations of  1E-6M and higher (ANOVA, p<0.05). 
Vessels from PCS constricted significantly stronger than vessels from 
VD at histamine concentrations of 1E-6M and higher, whereas vessels 
from ECS showed a significantly stronger contraction compared to the 
VD group only at 1E-5M histamine (ANOVA, p=0.042).
3.3. Tetrazolium dye reduction
The metabolic state of the vessels as measured by their capacity to re-
duce MTS was not  significantly  different  (ANOVA, p=0.673)  between 
samples from PCS (OD
490
=0.843±0.340, n=7), from ECS (0.915±0.327, 
n=6), and from VD (0.770±0.264, n=9). There was also no correlation 
with the duration of ischemia (r2=0.019, Fig. 3).
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3.4. Platelet adhesion
There was no significant difference (ANOVA, p=0.912) in the adhesion 
of platelets to HUV obtained from PCS (0.177%±0.094, n=3), from ECS 
(0.178%±0.046, n=3), and from VD (0.160%±0.061, n=5).
3.5. Prostacyclin release
The rates of prostacyclin release from the luminal faces of HUV were 
significantly higher in veins obtained from PCS and from ECS com-
pared to veins obtained from VD (two-way ANOVA, p<0.001, Fig. 5). 
The rates were computed as 6.93 ng⋅ml-1⋅min-1 (correlation coefficient: 
0.95, n=7), 3.67 ng⋅ml-1⋅min-1 (0.96, n=6) and 1.05 ng⋅ml-1⋅min-1 (0.95, 
n=10) for PCS, ECS, and VD, respectively.
3.6. Vessel structure
The evaluation of the luminal vessel surface by scanning electron mi-
croscopy revealed no significant difference (rank-sum test, p=0.944) in 
endothelial coverage between PCS (n=10) and VD (n=4). The former res-
ulted in a median of 80% coverage (25% percentile: 60%, 75% percent-
ile: 90%), whereas the latter resulted in 75% (55%, 95%). The histolo-
gical images (Fig. 6) of HUV cross sections also demonstrated an intact 
endothelium and a mostly unstructured smooth muscle layer with a 
low content of elastic fibers. None of the vessel sections contained any 
signs of mechanical alterations, regardless of the mode of delivery.
3.7. Correlations with other parameters
The maximum contraction with potassium chloride, the EC
50
 values of 
serotonin, and the prostacyclin release were found to be significantly 
influenced by the birth mode. We also evaluated the influence of arter-
ial pH, gestational age, birth weight, age of the mother, sex of the baby, 
storage solution, and duration of ischemia on these functional proper-
ties. There were no significant differences between HUV from male and 
from female babies, or between veins stored in KHB and in HF-1 in 
terms of  their  functional  properties  (ANOVA).  The  correlation coeffi-
cients r2 of all other correlations ranged between 2.34E-4 and 0.143 
and were considered too low to contribute to the observed differences.
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4. Discussion
To the best of our knowledge this is the first comprehensive study that 
investigates the impact of the different modes of birth on the function 
of HUV. Recent advances in tissue engineering  [4] have turned HUV 
into a promising biomaterial. The compliance of HUV was shown to be 
comparable to human saphenous vein, one of the most common by-
pass materials [15]. Cryopreserved HUV could be combined with fresh 
or  cryopreserved,  recipient-matched  endothelial  cells [16] and  pro-
cessed in a pulsatile bioreactor to create customized vascular grafts. 
This study tried to address the question if and how the mode of birth 
affects the functional properties of HUV and thus their utility as a bio-
material.
In general, PCS are considered less stressful for the fetus as compared 
to VD due to lower cord blood levels of the stress indicators cortisol, 
catecholamines, and β-endorphin [17-22]. There is also evidence that 
vaginal deliveries are associated with an increased oxidative stress [10] 
compared to c-sections. Therefore the working hyphothesis was that 
the lower level of stress in PCS will manifest itself beneficially in func-
tional properties of HUV.
The maternal characteristics observed in the births that were included 
in our study are well in agreement with the long-term experiences in 
OB/GYN departments. The gestational age of births terminated by a 
PCS were significantly shorter compared to the other birth modes. This 
is a consequence of the definition of this group, as it contains all births 
before the onset of labor. This shorter duration of the pregnancies also 
explains the reduced birth weight. The only significant difference that 
is surprising at first is the longer duration of ischemia in PCS as com-
pared to the other modes. All PCS except one were performed between 
8:32 and 12:32 as they can usually be scheduled for the most conveni-
ent time of the day, whereas VD and ECS were distributed more ran-
domly throughout the day. Thus the fixed pickup time in the morning 
skewed the distribution of ischemia times in favour of VD and ECS.
The reduction of tetrazolium dyes by membrane-bound enzymes is a 
marker for the redox state of cells and tissues [23]. MTS is reduced 
mainly intracellularly and is thus linked to the mitochondrial metabol-
ism, indirectly reflecting the potential to generate ATP [24]. We used 
the reduction of MTS as well as the contractile force to assess the pos-
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sible influence of the duration of ischemia on the vessel function. There 
was  no  correlation  between  ischemia  time  and  MTS  reduction,  or 
between ischemia time and the contractions elicited by KCl or sero-
tonin. Therefore it is safe to store umbilical cords for up to 40 hours 
under the conditions used in our study without a change of the redox 
state or of the contractile forces, which makes sample collection for tis-
sue engineering purposes reasonably simple.
Sterility of the samples is crucial for their use as living scaffolds, as 
they cannot be sterilized like acellular scaffolds. Both storage solutions 
were supplied in sterile containers and included standard antibiotics to 
prevent  bacterial  growth.  Visual  and microscopic  inspections of  the 
storage solutions did not reveal any contaminations at the time of ar-
rival in the lab. However, there is obviously no reliable way to obtain 
truly  sterile  umbilical  cord  samples  from  VD.  On  the  other  hand, 
planned c-sections are performed from the start within the sterile en-
vironment of a surgical theatre and while the amniotic sac is still in-
tact,  allowing  the  removal  and storage  of  the  umbilical  cord  under 
sterile conditions.
The birth modes differ in the amount of mechanical strain put on the 
umbilical cord. In c-sections the placenta is separated manually from 
the directly accessible uterus, whereas in vaginal births the delivery of 
the placenta may be assisted by gently pulling the remainder of the 
umbilical cord. However, umbilical cords are uniquely constructed to 
withstand both compression and elongation without harming the um-
bilical  circulation [25],  which  makes  mechanical  alterations  of  the 
veins unlikely. The evaluation of the histological sections as well as of 
the scanning electron micrographs revealed no differences in the vessel 
structure and luminal surface, respectively, that would exceed the vari-
ation within the PCS group and thus could be seen as a consequence 
of any additional strain in the VD and ECS groups. The cross sections 
indicated an intact endothelium and an undisturbed smooth muscle 
layer. The minor endothelial damage seen in the en face scanning elec-
tron micrographs is likely due to preparation artifacts and was not dif-
ferent between birth modes. Therefore, umbilical cords from all three 
modes are equally suitable for tissue engineering purposes with regard 
to their structural integrity.
The vasomotor response of the veins were evaluated for two reasons. 
First, the vasoconstriction, along with the tetrazolium dye reduction, 
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may serve as a measure for the functional integrity of the cells.  Al-
though long-term incubations in a bioreactor were outside the scope of 
the present study, it is reasonable to assume that undamaged cells will 
perform better in a tissue engineering scenario. Second, an appropriate 
vasomotor function is desirable in the finished graft, as it allows the 
vessel  to  respond to  endogenous and pharmacological  stimuli.  HUV 
from  VD showed  a  significantly  lower  maximum  contraction  in  re-
sponse to potassium chloride compared to PCS. The maximum con-
traction of  ECS was intermediate.  As the  mitochondrial  metabolism 
was unaffected by the mode of birth, it seems unlikely that the reduced 
maximum contraction is due to a lack of intracellular energy sources. 
We are aware that our experiments were not designed to distinguish 
between a temporary reduction of contractile force in response to an 
exhaustion  of  required  factors  and  a  more  serious  damage  which 
would not allow a recovery. In any case, the differences persisted long 
enough to be detectable up to 40 h after birth.
Histamine acts as a vasorelaxant in some vascular beds due to an in-
teraction with the endothelium [26], whereas higher doses of histamine 
cause  a  vasoconstriction  by  a  direct  interaction  with  the  smooth 
muscle cells [27]. The maximum contractions in our experiments were 
significantly lower in vessels obtained from VD as compared to the c-
section groups. This indicates that the contractile capacity is dimin-
ished in the VD group, irrespective of the agent that causes the vaso-
constriction.
Serotonin elicits a stronger vasoconstriction compared to thromboxane 
and norepinephrine in HUV [4]. This makes serotonin best suited to in-
vestigate the effects of the birth mode on receptor-mediated vasocon-
striction. The EC
50
 values of both c-section groups were significantly 
lower compared to the VD group. It is reasonable to assume that the 
values obtained from PCS best reflect the situation in utero, and that 
the values obtained from VD are caused by factors which are specific 
for  this birth mode, like hour-long uterine contractions,  stress,  and 
maternal pain. In ECS, the fetus can suffer from the same amount of 
labor-induced stress with the exception that it does not pass the birth 
canal. Interestingly, there is no difference in the EC
50
 values of sero-
tonin between the two c-section groups, although the duration of la-
bour in ECS can be the same as in VD. The passage through the birth 
canal may therefore contribute to the factors that cause a desensitiza-
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tion of HUV towards serotonin, which is in accordance with the hypo-
thesis that serotonin is involved in the closure of the umbilical circula-
tion [28].





 receptors [29-31]. Cord blood serotonin levels were reported to be 
2.8 times higher after VD compared to PCS in bovine [32]. A desensitiz-
ation of 5-HT receptors may thus explain the lower potency of sero-
tonin in the VD group, although further studies with selective agonists 
and antagonists would have to reveal which of the receptor subtypes is 
involved.
Endogenous prostacyclin is both a vasodilator and a potent antithrom-
botic  compound [33,34] which  relaxes  umbilical  arteries  more  effi-
ciently than nitric oxide [35]. A sufficient prostacyclin release is obvi-
ously desirable in vessel grafts to provide for an antithrombotic sur-
face. Our current data indicate a significantly higher rate of prostacyc-
lin release from veins in both c-section groups compared to the VD 
group.
The  medication  of  expectant  mothers  may  influence  the  functional 
properties of the HUV as well and could potentially explain the differ-
ences that we observed between the birth modes. The medication was 
applied according to the individual requirements of each patient and 
thus was very  heterogenous,  both among  patients  within  the  same 
birth mode group and between the participating medical centers. The 
limited number of cases per substance did not allow a statistical evalu-
ation. Instead we tried to identify medications 1) which have a mechan-
ism  of  action  that  may  interfere  with  the  functional  properties,  2) 
which are likely to cross the placenta, and 3) whose application shows 
a distribution between birth modes in the specific sets of experiments 
that parallels the observed differences. Of all substances administered 
to the patients in the last 24 h before birth, only metoclopramide (used 
to improve stomach motility) meets these criteria to hypothetically ex-
plain the results of the organ bath experiments. However, this sub-
stance has been described as a dopamine D
2
 receptor antagonist and a 
5-HT
3
 antagonist which does not affect placental vein contractions as 
these are mediated by the 5-HT
2
 receptor [36]. Oxytocin matches the 
pattern of the prostacyclin results if one assumes an inhibitory role. 
However, the substance is known to promote instead of inhibit prosta-
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cyclin release [37]. Within the limitations of this approach we consider 
it unlikely that the functional differences of HUV can be attributed to 
the medication of the expectant mothers.
Although we have shown in a previous study that HUV can be cryop-
reserved and seeded with EC [4], the feasibility of a tissue engineering 
process based on this biomaterial needs to be evaluated in future stud-
ies. It remains to be shown whether the smooth muscle layer of HUV is 
capable of adapting to increasing pressure and shear forces either in a 
pulsatile bioreactor or in a xenogenic transplant model [38]. However, 
as HUV consist of fetal tissue which continuously adapts to an increas-
ing umbilical blood flow during pregnancy, growth and ECM synthesis 
should be at least comparable to tissue-engineered products which use 
adult recipient-derived smooth muscle cells or fibroblasts. Immunolo-
gically, a deendothelialized HUV is an allogeneic transplant, even when 
seeded with the recipient's EC. HUV have so far only been used as a 
glutaraldehyde-fixed  graft  for  peripheral  revascularization  with  good 
results [39]. However, these results cannot easily be transferred to a 
tissue-engineered  graft  based  on  deendothelialized  HUV.  The  latter 
lacks the tanning process, which at least partially masks the antigenic 
sites, but will be covered by the recipient's own endothelium. Such an 
endothelium has been shown to establish full hemocompatibility of ar-
terial allografts without immunosuppression with a patency of several 
years [40]. To show that the same holds true for a HUV-based graft 
was beyond the scope of the current study.
5. Conclusion
This study has shown that a simplified sample collection protocol in-
volving a once-per-day pickup does not negatively affect the perform-
ance of HUV as a starting material for tissue engineering purposes. The 
data suggest that vessels obtained from c-sections provide better con-
tractility and superior prostacyclin release rates than those obtained 
from vaginal deliveries. In future, attention has to be paid to the mode 
of delivery when selecting vessels as a biomaterial for vascular tissue 
engineering. Experiments are currently under way in a perfusion model 
to investigate whether the observed differences persist or level out dur-
ing tissue engineering procedures.
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Figure 1: Comparison of the maximum tension of umbilical veins after depolarizing the vessel rings with potassium 
chloride (black bars) and after administering serotonin (grey bars) between vaginal delivery (VD, n=9), planned c-
section (PCS, n=8), and emergency c-section (ECS, n=6). * significantly different from VD (ANOVA, p = 0.029).
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Figure 2: Serotonin dose-response curves of umbilical vein rings obtained from planned c-sections (PCS; n=8, open 
circles, panel A) and from emergency c-sections (ECS; n=6, open squares, panel B). Both are compared against the 
curve obtained with rings from vaginal deliveries (VD; n=9, closed circles). The EC50 values of each curve were 
calculated using nonlinear regression and are indicated as diamonds.  *, EC50 values are significantly different from 
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VD (ANOVA, p < 0.05).
Figure 3: Lack of correlation of the maximum constriction by potassium chloride (A), of the MTS reduction (B), of the 
maximum constriction by serotonin (C), and of the EC50 of serotonin (D) with the duration of ischemia. Filled circles, 
vaginal deliveries (VD); open circles, planned c-sections (PCS), filled triangles, emergency c-sections (ECS). The 
solid lines indicate the linear regressions of all samples regardless of the birth mode, the dashed lines indicate the 
95% confidence intervals.
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Figure 4: Histamine dose-response curves of umbilical vein rings obtained from planned c-sections (PCS; n=5, open 
circles), from emergency c-sections (ECS; n=7, filled triangles), and from vaginal deliveries (VD; n=7, closed circles). 
The values are plotted as the ratio of the tension after Histamine adminstration and the tension of matched time 
controls. Values less than unity (dashed line) indicate a relaxation, values higher than unity a constriction. * 
significantly different from unity (two-way repeated measurements ANOVA, p < 0.05). § significantly different from VD 
(two-way ANOVA, p = 0.042).
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Figure 5: Time-dependent prostacyclin release from umbilical veins obtained from planned c-sections (PCS; n=7, 
open circles), from emergency c-sections (ECS; n=6, filled triangles), and from vaginal deliveries (VD; n=10, closed 
circles). * significantly different from VD (two-way ANOVA, p < 0.001).
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Figure 6: Comparison of HUV cross sections (Russel-Movat Pentachrome stain) of vaginal deliveries (A), primary c-
sections (B), and emergency c-sections (C). The images are representative for 6 vessels per birth mode. The bars 
indicate 50µm.
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parameter vaginal delivery planned c-section emergency c-section
number (male / female) 40 (19 / 21) 19 (7 / 12) 18 (10 /  8)
maternal age (y) 29.8 (21 - 38) 31.7 (25 - 38) 33.1 (26 - 43)
gestational age (d) 277.6 (251 - 293) 267.1 (258 - 285) * 275.1 (259 - 288)
birth weight (g) 3487.8 (2500 - 4470)
2873.8 (2025 - 3730) 
§ 3108.9 (2620 - 3550)
arterial cord blood pH 7.24  (7.08 - 7.42) 7.28 (7.14 - 7.39) 7.26 (7.09 - 7.34)
Apgar score 1' 8.65 (6 - 10) 8.28 (7 - 9) 7.94 (5 - 10)
Apgar score 5' 9.68 (8 - 10)
9.06 (8 - 10) 
§
9.11 (8 - 10) 
§
Apgar score 10' 9.84 (9 - 10)
9.28 (8 - 10) 
§
9.44 (9 - 10) 
§
ischemia time (min) 1009 (277 - 2443)
1465 (77 - 1543) 
‡ 1203 (258 - 2123)
Table 1: Birth parameters of the umbilical cords used in this study. Except for the number of births, all data are 
reported as mean (range). Ischemia time is reported as median (range). * significantly different from vaginal delivery 
and from emergency c-section (ANOVA, p<0.001);  § significantly different from vaginal delivery (ANOVA, p<0.001); 
‡ significantly different from vaginal delivery (ANOVA, p=0.043).
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